Processa shareholders approve 10x authorized share increase and reverse split

Processa Pharmaceuticals, Inc.

• Shareholders approved increase in authorized common shares from 100M to 1B (13.7M for, 3.0M against).
• Reverse stock split approved with ratio ranging from 1:2 to 1:50, at board's discretion, by Dec 31, 2026.
• Amendment to 2019 Omnibus Incentive Plan to increase shares available for issuance approved (13.6M for).
• All four proposals passed at special meeting held Sep 11, 2025.